BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 25270087)

  • 1. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
    Nantajit D; Lin D; Li JJ
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.
    Li P; Yang R; Gao WQ
    Mol Cancer; 2014 Mar; 13():55. PubMed ID: 24618337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epithelial-mesenchymal transition in regulating radioresistance.
    Zhou S; Zhang M; Zhou C; Wang W; Yang H; Ye W
    Crit Rev Oncol Hematol; 2020 Jun; 150():102961. PubMed ID: 32361589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
    Jin W
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities.
    Choi HY; Yang GM; Dayem AA; Saha SK; Kim K; Yoo Y; Hong K; Kim JH; Yee C; Lee KM; Cho SG
    Breast Cancer Res; 2019 Jan; 21(1):6. PubMed ID: 30651129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
    BharathwajChetty B; Sajeev A; Vishwa R; Aswani BS; Alqahtani MS; Abbas M; Kunnumakkara AB
    Cancer Metastasis Rev; 2024 Mar; 43(1):321-362. PubMed ID: 38517618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.
    Dongre A; Weinberg RA
    Nat Rev Mol Cell Biol; 2019 Feb; 20(2):69-84. PubMed ID: 30459476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
    Lu W; Kang Y
    Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cells: Multiple capacities in tumor metastasis.
    Geng SQ; Alexandrou AT; Li JJ
    Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance.
    Lim S; Becker A; Zimmer A; Lu J; Buettner R; Kirfel J
    PLoS One; 2013; 8(6):e66558. PubMed ID: 23799116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
    Dalla Pozza E; Forciniti S; Palmieri M; Dando I
    Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer.
    Chattopadhyay I; Ambati R; Gundamaraju R
    Mediators Inflamm; 2021; 2021():9918379. PubMed ID: 34220337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
    Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
    Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance.
    Xu Z; Zhang Y; Dai H; Han B
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.